Bhatt, A., Vaduganathan, M., Jena, B., Suminska, S., Eid, C., Khairnar, R., et al. (2024). Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE, 26(5), 1172-1174 [10.1002/ejhf.3233].

Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction

Senni M.
2024

Lettera in rivista
Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Drug Combinations; Female; Heart Failure; Humans; Male; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan
English
7-apr-2024
2024
26
5
1172
1174
none
Bhatt, A., Vaduganathan, M., Jena, B., Suminska, S., Eid, C., Khairnar, R., et al. (2024). Comparative effectiveness of sacubitril/valsartan versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with de novo heart failure with mildly reduced and preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE, 26(5), 1172-1174 [10.1002/ejhf.3233].
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/524386
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
Social impact